Gemcitabine Sensitivity is Improved in Pancreatic Cancer by CYR61/CCN1-Depletion-Mediated Upregulation of dCK and Suppression of CTGF

被引：0
|
作者：
Ghosh, Arnab
Maity, Gargi
Gupta, Vijaylaxmi
Haque, Inamul
Sarkar, Sandipto
Das, Amlan
Dhar, Kakali
Bhavanasi, Sneha
Gunewardena, Sumedha S.
Von Hoff, Daniel D.
Mallik, Sanku
Kambhampati, Suman
Banerjee, Sushanta
Banerjee, Snigdha
机构：
来源：
FASEB JOURNAL | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
647.8
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Pancreatic Tumor Cell Secreted CCN1/Cyr61 Promotes Endothelial cell migration and Aberrant Neovascularization
    Gargi Maity
    Smita Mehta
    Inamul Haque
    Kakali Dhar
    Sandipto Sarkar
    Sushanta K. Banerjee
    Snigdha Banerjee
    Scientific Reports, 4
  • [32] Cyr61/CCN1 affects the integrin-mediated migration of prostate cancer cells (PC-3) in vitro
    Schmitz, Patrick
    Gerber, Ursula
    Juengel, Eva
    Schuetze, Norbert
    Blaheta, Roman
    Bendas, Gerd
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (01) : 47 - 50
  • [33] Fas-Mediated Apoptosis Is Regulated by the Extracellular Matrix Protein CCN1 (CYR61) In Vitro and In Vivo
    Juric, Vladislava
    Chen, Chih-Chiun
    Lau, Lester F.
    MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (12) : 3266 - 3279
  • [34] CCN1/Cyr61 regulates Sonic Hedgehog Signaling through Activation of Notch-1 in Pancreatic Carcinogenesis: A Novel Targeting Pathway for Pancreatic Cancer Therapy
    Haque, Inamul
    De, Archana
    Majumder, Monami
    Mehta, Smita
    McGregor, Douglas
    Banerjee, Sushanta K.
    Van Veldhuizen, Peter
    Banerjee, Snigdha
    FASEB JOURNAL, 2013, 27
  • [35] Matricellular protein Cyr61/CCN1 regulates the sternness of oral cancer stern-like cells
    Chang, Chih-Hao
    Leu, Shih-Jeng
    Lo, Jeng-Fan
    CANCER RESEARCH, 2011, 71
  • [36] Cyr61 (CCN1) is a novel target for Zometa (zoledronic acid) in breast cancer bone metastasis.
    Espinoza, I
    Liu, H.
    Dimri, M.
    Lupu, R.
    CANCER RESEARCH, 2009, 69 (02) : 225S - 226S
  • [37] Cyr61 and FOXOAI are inversely regulated in IGF-1 mediated breast cancer cells
    Sarkissyan, Suren
    Sarkissyan, Marianna
    Wu, Yanyuan
    Koeffler, H. Phillip
    Vadgama, Jaydutt V.
    CANCER RESEARCH, 2011, 71
  • [38] Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
    Lai, Dulcie
    Ho, King Ching
    Hao, Yawei
    Yang, Xiaolong
    CANCER RESEARCH, 2011, 71 (07) : 2728 - 2738
  • [39] Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein connexin43 in glioma cells
    Sin, Wun Chey
    Bechberger, John F.
    Rushlow, Walter J.
    Naus, Christian C.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 103 (06) : 1772 - 1782
  • [40] Activation of Wnt/β-catenin signaling pathway enhances pancreatic cancer development and the malignant potential via up-regulation of Cyr61/CCN1
    Sano, Makoto
    Driscoll, David R.
    DeJesus-Monge, Wilfredo E.
    Quattrochi, Brian
    Appleman, Victoria A.
    Ou, Jianhong
    Zhu, Lihua Julie
    Yoshida, Nao
    Yamazaki, Shintaro
    Takayama, Tadatoshi
    Sugitani, Masahiko
    Nemoto, Norimichi
    Klimstra, David S.
    Lewis, Brian C.
    CANCER RESEARCH, 2016, 76
12345